NEW YORK, NY - September 25, 2012 -- MomentumHunter.com is a premier source for microcap research - providing a wide range of due diligence and investment insight on stocks all over the market. MomentumHunter.com Investment Report primary focus is to alert our valued subscribers to small cap and microcap companies poised for explosive movement in the market. As every investor knows, timing in the market is critical! To receive our FREE comprehensive newsletter, please visit MomentumHunter.com
Today MomentumHunter.com announces eight stocks to watch closely: Pristine Solutions (OTCBB: PRTN), Save the World Air (OTCBB: ZERO), Applied DNA Scineces (OTCBB: APDN), Cellceutix Corp (OTCBB: CTIX) and Amarantus Biosciences (AMBS), Advanced Cell Tech (ACTC), SiriusXM (SIRI), Southridge Enterprises (SRGE).
Pristine Solutions (OTCBB: PRTN), through its wholly-owned subsidiary company, Eaton Scientific Systems, Ltd., holds the intellectual property and global marketing rights to Tropine 3, a patent pending novel indication of an existing FDA approved drug for the non-hormonal treatment of hot flashes in pre-menopausal, peri-menopausal, and post-menopausal women
Save the World Air (OTCBB: ZERO) develops and commercializes energy efficiency technologies that assist in meeting increasing global energy demands, improving the economics of oil extraction and transport, and reducing greenhouse gas emissions. STWA's technologies include Applied Oil Technology(TM) (AOT(TM)), which is designed to improve oil flow through pipelines.
Applied DNA Scineces (OTCBB: APDN) is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Cellceutix Corp (OTCBB: CTIX) is an emerging bio-pharmaceutical company focused on the development of its pipeline of compounds targeting areas of unmet medical need. The Company's flagship compound, Kevetrin(TM), is an anti-cancer drug which has demonstrated the ability in pre-clinical studies to regulate the p53 pathway and attack cancers which have proven resistant to today's cancer therapies (drug-resistant cancers).
At www.MomentumHunter.com we know that nothing speaks louder than our picks and the success of our subscribers! In today's markets, investors need to be in the know. Knowledge is more than power, its money. That's why our team at MomentumHunter.com tracks the hottest stocks all over the market in order to keep our subscribers tuned in. We focus mainly on microcap, small cap and penny stock companies - companies that allow our investors to bring home big profits. We work diligently and provide all investors - large or small - an opportunity to track stocks with the potential to make big gains.
Join our FREE newsletter at MomentumHunter.com today and receive our next Ultra Stock Alert coming out next week.
MomentumHunter.com alerts investors to promising small cap companies, many (if not all!) are overlooked by your run of the mill Wall Street investment advisors. At MomentumHunter.com, we know it is easier to find a stock that can go from $0.01 - $1.00 in days or weeks, than it is to find a stock that can go from $1.00 - $100.00 in months or years. MomentumHunter.com provides its subscribers with comprehensive public information and due diligence for small companies with huge potential.
While many of the other investment newsletters talk a big game, at MomentumHunter.com we let our research do the talking! We invite you to give us a try and sign up for free today at http://www.MomentumHunter.com
Contacts:
MomentumHunter.com
Editor
(888) 406-0811
info@MomentumHunter.com
FNM Disclosure: FN Media Group, LLC (FNMG) is a news dissemination & third party publishing service provider and is not affiliated or associated with any company or entity mentioned or listed herein. If you're a company interested in having FN Media Group assist you with creating a greater awareness for your next news release utilizing our multi-media and leading edge outreach solutions, contact us now at info@financialnewsmedia.com. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as a recommendation or research material, nor an offer or solicitation to buy or sell securities. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made herein. For disseminating this release, FNMG was compensated one thousand dollars for distribution of this release.
Contact email: editor@financialnewsmedia.com
Company: FN Media Group, LLC